Mayo Clinic_Arizona
Phoenix, Arizona 98195
44 studies enrolling now · 223 studies all time
What they study most
ACL Injury, ADHF, AFP Expressing Tumors, AML, Acute Blood Loss, Acute Coronary Syndrome, Acute Illness, Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Myeloid Leukemia (AML) With, Acute Myocardial Infarction
Studies at this site
- A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma — Recruiting now
- Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer — Recruiting now
- Adverse Outcomes and Mortality in Liver Transplant — Recruiting now
- Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM — Recruiting now
- Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure — Recruiting now
- Post-Market Study to Assess iTind Safety in Comparison to UroLift — Recruiting now
- (Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis — Recruiting now
- Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study — Recruiting now
- Inobrodib, Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma — Recruiting now
- AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe Epilepsy — Recruiting now
- A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer — Recruiting now
- A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma — Recruiting now
- DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers — Recruiting now
- Pancreatic Cancer Early Detection Consortium — Recruiting now
- A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors — Recruiting now
- A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC) — Recruiting now
- A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer — Recruiting now
- A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer — Recruiting now
- Diagnosing Epilepsy To EffeCT Change — Recruiting now
- Diagnosing Epilepsy To EffeCT Change Long-Term Follow-Up — Recruiting now
- Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302) — Recruiting now
- SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance) — Recruiting now
- Treatment of Antibody-Mediated Rejection (ABMR) With CarBel — Recruiting now
- Chronic Subdural Hematoma Treatment With Embolization Versus Surgery Study — Recruiting now
- Low Sodium Oxybate in Patients With Idiopathic Hypersomnia — Recruiting now
- Disparities Among Liver Transplant Patients — Recruiting now
- ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study) — Recruiting now
- ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack — Recruiting now
- Safety Study of Unlicensed IND Cord Blood Units Manufactured by the National Cord Blood Program for Unrelated Transplantation — Recruiting now
- A Study of CTX-712 in Relapsed/Refractory Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes — Recruiting now
- Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer — Recruiting now
- Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC — Recruiting now
- Avapritinib With Decitabine in Patients With SM-AHN — Recruiting now
- Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease — Recruiting now
- Study of SIM0500 Alone in Participants With Relapsed or Refractory Multiple Myeloma — Recruiting now
- Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS) — Recruiting now
- Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM) — Recruiting now
- BRAZAN: A Randomized Phase 2 Study of Bendamustine, Rituximab, Cytarabine (AraC) Induction With Zanubrutinib (BRAZAN) Followed by Zanubrutinib/Rituximab +/- Sonrotoclax Maintenance in Treatment-Naïve Mantle Cell Lymphoma — Recruiting now
- A Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03) — Recruiting now
- A First-in-Human Study of YL217 in Patients With Advanced Solid Tumors — Recruiting now
- Study of Biomarker-Based Treatment of Acute Myeloid Leukemia — Recruiting now
- CAR-T Long Term Follow Up (LTFU) Study — Recruiting now
- Safety and Device Performance of the Uriprene® Degradable Temporary Ureteral Stent Following Uncomplicated Ureteroscopy — Recruiting now
- Accelerated Resolution Therapy for Early Maladaptive Grief — Recruiting now
- Dual BET and CBP/p300 Inhibitor in Patients With Targeted Advanced Solid Tumors and Hematological Malignancies — Recruiting now
- A Study of SPX-303, a Bispecific Antibody Targeting LILRB2 and PD-L1 in Patients With Solid Tumors — Recruiting now
- A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Participants With Metastatic Prostate Cancer — Running, not enrolling
- Expanded Access Program for Daraxonrasib (RMC-6236) in Previously Treated Metastatic Pancreatic Adenocarcinoma — Available (expanded access)
- Selatogrel Outcome Study in Suspected Acute Myocardial Infarction — Enrolling by invitation
- Bemarituzumab Plus Chemotherapy and Nivolumab Versus Chemotherapy and Nivolumab for FGFR2b Overexpressed Untreated Advanced Gastric and Gastroesophageal Junction Cancer. — Stopped early